Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2024-01-10 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于调整第四届董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about changes in its board committees, specifically the resignation of an independent director, the appointment of new members to the board's specialized committees, and adjustments to comply with regulatory requirements. It includes details about the board members before and after the changes and the dates of relevant meetings and approvals. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and management structure, fitting the category of Board/Management Information.
2024-01-10 Chinese
董事会战略委员会议事规则（2024年1月）
Governance Information Classification · 95% confidence The document is titled '董事会战略委员会议事规则' which translates to 'Board Strategic Committee Meeting Rules'. It details the composition, responsibilities, decision-making procedures, and meeting rules of the company's board strategic committee. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, and no mention of any report publication. The document is a governance-related internal rules document about board committee operations. Therefore, it fits best under Governance Information (CGR). The document length is 1924 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2024-01-10 Chinese
第四届董事会第三十七次（临时）会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a specific board meeting of the company, detailing changes to board committees and their rules. It includes voting results and references to related disclosures. The content focuses on board and committee structure and governance matters, not on financial results or reports. The document length is short (1452 characters), and it is clearly a formal announcement of board decisions rather than a full report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-01-10 Chinese
董事会薪酬与考核委员会议事规则（2024年1月）
Governance Information Classification · 100% confidence The document is titled as the "Board of Directors' Remuneration and Assessment Committee Rules" of a company. It details the structure, responsibilities, procedures, and rules governing the remuneration and assessment committee of the board. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, no earnings release, no merger or acquisition information, and no regulatory filing or certification. The content is focused on governance practices related to board remuneration and assessment. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-01-10 Chinese
关于为全资子公司提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the progress of guarantees provided by the company to its wholly-owned subsidiaries. It includes financial data of the subsidiaries, descriptions of guarantee agreements, board meeting approvals, and risk disclosures. The content focuses on updates about financing guarantees rather than financial results, management changes, or legal proceedings. It is not a full financial report, earnings release, or audit report. The document is a formal announcement about capital/financing activities related to guarantees for subsidiaries. Therefore, it fits best under the category 'Capital/Financing Update (CAP)'. The document length is 4324 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2024-01-08 Chinese
上海澄明则正律师事务所关于绿康生化股份有限公司2024年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the 2024 first extraordinary general meeting (临时股东大会) of a company. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, confirming compliance with laws and company articles. This type of document is not the meeting materials themselves (AGM Information), nor is it a report of voting results alone. It is a legal opinion related to a shareholders' meeting, which is typically classified under Regulatory Filings (RNS) as it does not fit other categories like DVA (which is strictly voting results announcements) or AGM-R (which are presentations/materials). The document is over 5,000 characters and contains substantive legal opinion content, not just an announcement or certification. Therefore, the best fit is Regulatory Filings (RNS).
2024-01-05 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.